The Democratic Republic of the Congo is currently grappling with the fastest-growing Ebola outbreak in its history. Since the Bundibugyo strain was officially identified on 15 May, the virus has spread more rapidly than in any of the country’s 16 prior outbreaks. Congolese health officials have now recorded 3,360 confirmed cases across five eastern provinces, with the death toll reaching 1,487. This results in an estimated case fatality rate of approximately 45%.
The situation is approaching the scale of the 2018-2020 outbreak, which saw 3,470 infections. Prof Pierre Akilimali of the country’s public health institute, who is leading the response, noted that the disease remains difficult to track, and the path to controlling the spread is lengthy. He highlighted that issues such as insecurity, mining operations, and high population density in regions like Ituri make this current crisis significantly more complex than previous ones. New confirmed infections continue to rise, averaging between 100 and 150 per week in the Bunia and Rwampara health zones.
Local residents expressed significant distress over the ongoing crisis. Deborah Nzuva, a mother of four living in Rwampara, described the atmosphere as one where life feels as though it may come to a total standstill. Clothing trader Annabelle Nissi echoed these concerns, stating that the outbreak has disrupted daily life and stalled local development projects.
In response, authorities have implemented several measures, including the establishment of over 20 Ebola treatment centres, the creation of local testing laboratories, and the deployment of community liaison officers to improve surveillance. Dr Justus Nsio, field incident manager for the Africa Centres for Disease Control and Prevention, acknowledged that the outbreak was detected too late, necessitating an intense effort to contain the virus. He expressed optimism that, with the commitment of partners, a favourable outcome is still possible.
As there is no standard treatment for the Bundibugyo strain, clinical trials for a potential vaccine began in early July. Prof Placide Mbala, who oversees laboratory operations, reported that approximately 20 people had been enrolled in the trials as of 15 July, with the study expected to last up to four months. Meanwhile, experts from Uganda, which recently declared its own Ebola outbreak over, have been sent to assist in border regions like Tchomia and Kasenyi.
As the death toll rises to almost 1,500, and with a vaccine against the Bundibugyo strain potentially still months away, health workers face a battle to slow the outbreak
“This outbreak is causing us great distress. Our hope lies solely in God’s hands. It continues to disrupt our lives and has brought our development projects to a standstill,” she said.
